Check out the companies making the biggest moves in intraday trading. Abbott Laboratories, the maker of Ensure Nutrition Shakes, soared nearly 11%. Abbott raised its full-year adjusted earnings forecast, expecting it to be in the range of $5.45 to $5.60 per share, compared with its previous forecast of $5.38 to $5.58 per share. FactSet consensus was calling for $5.47 per share. ManpowerGroup – The recruitment company’s stock rose 33%. Manpower had expected sales to rise 2% to 6% in the third quarter, compared with the FactSet consensus estimate of 1.7%. Second-quarter adjusted earnings were 99 cents per share on revenue of $4.9 billion, beating Wall Street’s call for 95 cents per share and $4.72 billion. Cintas — Uniform rental and cleaning service shares rose 6.5% after Bank of America upgraded the stock to buy from neutral. The rating change comes after Cintas reported better-than-expected fourth-quarter profits on Wednesday. BofA said: “Cintas is gradually and constructively preparing for earnings in the coming quarters as it benefits from environmental improvements in key labor areas, continues to deliver impressive growth in adjacent product categories, and generates significant gains through a focus on improving supply chain and distribution efficiencies.” Cinemark, Imax — Shares of movie theater companies fell about 4% and 2%, respectively, after Wells Fargo was downgraded from overweight to equal weight. The company said these stocks have a more balanced risk-reward ratio. AST SpaceMobile — Shares of the satellite broadband company fell more than 16% after the company announced plans to sell $1 billion in convertible notes due in 2034 in a private placement. UnitedHealth — Shares rose 4% after the health insurance giant reported better-than-expected second-quarter results. The company had adjusted earnings per share of $112.03 billion and profit of $6.38. Analysts polled by LSEG had expected earnings of $4.90 per share and sales of $110.85 billion. UnitedHealth also raised its full-year profit outlook. Taiwan Semiconductor Manufacturing Co. — The chipmaker fell 2%. TSMC’s second-quarter profit beat expectations, but the company raised its full-year capital spending forecast to $60 billion to $64 billion, up from the high end of its previous forecast of $52 billion to $56 billion. The company also announced an additional $100 billion investment in Arizona. AtaiBeckley — The psychedelic drug maker soared 33% after Eli Lilly announced it would acquire AtaiBeckley for $2.8 billion. This equates to $6.75 per share in cash, 26% above Atai Beckley’s Wednesday closing price of $5.36 per share. Eli Lilly could pay up to an additional $2.50 per share if Ataibekly’s drug achieves certain milestones. Eli Lilly’s stock rose more than 2%. Rival psychedelic drug maker GH Research rose 12% on the news. GE Aerospace — Shares fell 4% despite the company’s second-quarter earnings and revenue beats. GE Aerospace reported adjusted earnings of $2.02 per share on adjusted revenue of $12.63 billion. Analyst estimates compiled by LSEG were for EPS of $1.86 and revenue of $11.86 billion. The company also raised its full-year forecast. United Airlines — Shares fell more than 1% despite the company beating profit estimates. The company issued softer-than-expected guidance of $2.50 to $3.50 per share for the third quarter. That compares with FactSet’s estimate of $3.53 per share. United Airlines also said it expects additional fuel costs to be $6 billion. JB Hunt Transport Services — Shares rose about 7% after the company reported second-quarter earnings of $1.91 per share, compared to the FactSet consensus of $1.74 per share. Sales came in at $3.5 billion, compared to expectations of $3.26 billion. Management said demand for intermodal transportation services increased throughout the quarter. AeroVironment — Shares rose 4% following Raymond James Company upgrade, outperforming the market. The company said bookings for AeroVironment are recovering and the backlog is trending upward. Rocket Companies — The fintech platform rose more than 1% after Morgan Stanley raised its price target to $19 and reiterated a buy rating. The new target suggests a 30% rise from Wednesday’s close. — CNBC’s Christina Cheddar Berk, Darla Mercado, Alex Harring, Fred Imbert and Tanaya Macheel contributed reporting.
